An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1
- PMID: 7666525
- PMCID: PMC189522
- DOI: 10.1128/JVI.69.10.6249-6258.1995
An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1
Abstract
Among the five immediate-early regulatory proteins of herpes simplex virus (HSV) type 1, only ICP0 is capable of activating all kinetic classes of viral genes. Consistent with its broad transactivating activity, ICP0 plays a major role in enhancing the reactivation of HSV from latency both in vivo and in vitro. Although not essential for viral replication, ICP0 confers a significant growth advantage on the virus, especially at low multiplicities of infection. In this report we describe the expression of a novel activity by the osteosarcoma cell line U2OS that can substitute functionally for ICP0. Compared with Vero cells, both U2OS cells and cells of the ICP0-expressing line 0-28 significantly enhanced the plating efficiency of an ICP0 null mutant, 7134. In contrast, the plating efficiencies of the wild-type virus in all three cell types were similar. Single-step growth experiments demonstrated that the yield of 7134 in U2OS cells was severalfold higher than that in 0-28 cells and about 100-fold higher than that in Vero cells. In order to identify the viral genes whose expression is enhanced by the activity in U2OS cells, levels of expression of selected viral proteins in extracts of Vero and U2OS cells were compared by Western blot (immunoblot) analysis following low-multiplicity infection. At a multiplicity of 0.1 PFU per cell, the levels of expression of the immediate-early protein ICP4 and the early protein gD in 7134-infected U2OS cells were significantly higher than those in 7134-infected Vero cells. When infections were carried out at a multiplicity of 1 PFU per cell, however, no major differences in the levels of expression of these proteins in U2OS and Vero cells were observed. Cycloheximide reversal experiments demonstrated that the cellular activity expressed in U2OS cells that promotes high-level expression of ICP4 is not synthesized de novo but appears to exist as a preformed protein(s). To confirm this observation and to determine whether, like immediate-early genes, early, delayed-early, and late viral genes are also responsive to the cellular activity, transient-expression assays were performed. The results of these tests demonstrated that basal levels of expression from immediate-early, early, and delayed-early promoters, but not that from a late promoter, were significantly higher in U2OS cells than in Vero cells and that this enhancement occurred in the absence of viral proteins.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells.J Virol. 1992 May;66(5):2904-15. doi: 10.1128/JVI.66.5.2904-2915.1992. J Virol. 1992. PMID: 1313909 Free PMC article.
-
Induction of herpes simplex virus type 1 immediate-early gene expression by a cellular activity expressed in Vero and NB41A3 cells after growth arrest-release.J Virol. 1994 Nov;68(11):6871-82. doi: 10.1128/JVI.68.11.6871-6882.1994. J Virol. 1994. PMID: 7933067 Free PMC article.
-
Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis.J Virol. 1997 Sep;71(9):6850-62. doi: 10.1128/JVI.71.9.6850-6862.1997. J Virol. 1997. PMID: 9261410 Free PMC article.
-
Regulation of alphaherpesvirus infections by the ICP0 family of proteins.J Gen Virol. 2013 Mar;94(Pt 3):465-481. doi: 10.1099/vir.0.048900-0. Epub 2012 Dec 12. J Gen Virol. 2013. PMID: 23239572 Review.
-
Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1.J Virol. 2004 Mar;78(5):2169-78. doi: 10.1128/jvi.78.5.2169-2178.2004. J Virol. 2004. PMID: 14963113 Free PMC article. Review. No abstract available.
Cited by
-
Vaccinia Virus B1 Kinase Is Required for Postreplicative Stages of the Viral Life Cycle in a BAF-Independent Manner in U2OS Cells.J Virol. 2015 Oct;89(20):10247-59. doi: 10.1128/JVI.01252-15. Epub 2015 Jul 29. J Virol. 2015. PMID: 26223647 Free PMC article.
-
Development of a regulatable oncolytic herpes simplex virus type 1 recombinant virus for tumor therapy.J Virol. 2010 Aug;84(16):8163-71. doi: 10.1128/JVI.00059-10. Epub 2010 Jun 2. J Virol. 2010. PMID: 20519407 Free PMC article.
-
Herpes simplex virus-infected cell protein 0 blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST-REST complex.Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17134-9. doi: 10.1073/pnas.0707266104. Epub 2007 Oct 15. Proc Natl Acad Sci U S A. 2007. PMID: 17939992 Free PMC article.
-
PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0.J Virol. 2006 Aug;80(16):7995-8005. doi: 10.1128/JVI.00734-06. J Virol. 2006. PMID: 16873256 Free PMC article.
-
Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100.J Virol. 2008 Mar;82(6):2661-72. doi: 10.1128/JVI.02308-07. Epub 2007 Dec 26. J Virol. 2008. PMID: 18160441 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources